tert-Butyl 7-oxa-2-azabicyclo[4.1.0]heptane-2-carboxylate

Catalog No. :
ACZCML503
CAS No. :
1262408-71-8
Molecular Formula :
C10H17NO3
Molecular Weight :
199.25

IUPAC Name:tert-butyl 7-oxa-2-azabicyclo[4.1.0]heptane-2-carboxylate

tert-Butyl 7-oxa-2-azabicyclo[4.1.0]heptane-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$186.00Login to see priceInquiryInquiry
250mg98%$297.00Login to see priceInquiryInquiry
1g98%$741.00Login to see priceInquiryInquiry
5g98%$2224.00Login to see priceInquiryInquiry
10g98%$3706.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 7-oxa-2-azabicyclo[4.1.0]heptane-2-carboxylate
IUPAC Nametert-butyl 7-oxa-2-azabicyclo[4.1.0]heptane-2-carboxylate
Molecular FormulaC10H17NO3
Molecular Weight199.25
SMILESO=C(N1C2OC2CCC1)OC(C)(C)C
InChI KeyLMEUWPRMSAYCBV-UHFFFAOYSA-N
Synonymtert-butyl 7-oxa-2-azabicyclo[4.1.0]heptane-2-carboxylate
CAS No.1262408-71-8

Safety Data

Pictogram
CorrosiveHealth hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H312-H315-H319-H350
Precautionary Statement(s)
P201-P202-P210-P261-P264-P271-P280-P302+P352+P312-P305+P351+P338-P308+P313-P337+P313-P370+P378-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZCML503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZCML503 route product structure diagram
    ACZCML5031262408-71-8
Inquiry

2. ACZCML503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRZOQ048 route compound structure diagram
    ACRZOQ048131667-57-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZCML503 route product structure diagram
    ACZCML5031262408-71-8
Inquiry

Comments (0)